These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23210816)

  • 1. Regulation, manufacturing and building industry consensus.
    Deans R
    Regen Med; 2012 Nov; 7(6 Suppl):78-81. PubMed ID: 23210816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Welcome to the World Stem Cell Report.
    Siegel B
    Regen Med; 2011 Nov; 6(6 Suppl):1-2. PubMed ID: 21999254
    [No Abstract]   [Full Text] [Related]  

  • 3. Hurdles in tissue engineering/regenerative medicine product commercialization: a pilot survey of governmental funding agencies and the financial industry.
    Bertram TA; Tentoff E; Johnson PC; Tawil B; Van Dyke M; Hellman KB
    Tissue Eng Part A; 2012 Nov; 18(21-22):2187-94. PubMed ID: 22838399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The strong financial case for regenerative medicine and the regen industry.
    Mason C; Dunnill P
    Regen Med; 2008 May; 3(3):351-63. PubMed ID: 18462058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemacord approval may foreshadow regulatory creep for HSC therapies.
    Allison M
    Nat Biotechnol; 2012 Apr; 30(4):304. PubMed ID: 22491271
    [No Abstract]   [Full Text] [Related]  

  • 6. Geron's quixotic fate.
    Scott C; Huggett B
    Nat Biotechnol; 2012 Jun; 30(6):497. PubMed ID: 22678383
    [No Abstract]   [Full Text] [Related]  

  • 7. Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from nonacademic institutions, 1 January-28 February 2017.
    Ilic D; Yau S
    Regen Med; 2017 Apr; 12(4):321-330. PubMed ID: 28621222
    [No Abstract]   [Full Text] [Related]  

  • 8. Global update: Japan.
    Sipp D
    Regen Med; 2011 Nov; 6(6 Suppl):160-2. PubMed ID: 21999281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manufacturing road map for tissue engineering and regenerative medicine technologies.
    Hunsberger J; Harrysson O; Shirwaiker R; Starly B; Wysk R; Cohen P; Allickson J; Yoo J; Atala A
    Stem Cells Transl Med; 2015 Feb; 4(2):130-5. PubMed ID: 25575525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global update: Germany.
    Lauter FR; Wirsching S
    Regen Med; 2011 Nov; 6(6 Suppl):154-7. PubMed ID: 21999280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balancing Safety and Innovation for Cell-Based Regenerative Medicine.
    Marks P; Gottlieb S
    N Engl J Med; 2018 Mar; 378(10):954-959. PubMed ID: 29514023
    [No Abstract]   [Full Text] [Related]  

  • 12. An Industry-Driven Roadmap for Manufacturing in Regenerative Medicine.
    Hunsberger JG; Shupe T; Atala A
    Stem Cells Transl Med; 2018 Aug; 7(8):564-568. PubMed ID: 30009571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The making of an advocate. Interview with Alan Fernandez.
    Fernandez A
    Regen Med; 2012 Nov; 7(6 Suppl):114-6. PubMed ID: 23210822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stromal cell therapy: a revolution in Regenerative Medicine?
    Bernardo ME; Pagliara D; Locatelli F
    Bone Marrow Transplant; 2012 Feb; 47(2):164-71. PubMed ID: 21478914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regenerative cells for transplantation in hepatic failure.
    Ishikawa T; Banas A; Teratani T; Iwaguro H; Ochiya T
    Cell Transplant; 2012; 21(2-3):387-99. PubMed ID: 22793046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision manufacturing for clinical-quality regenerative medicines.
    Williams DJ; Thomas RJ; Hourd PC; Chandra A; Ratcliffe E; Liu Y; Rayment EA; Archer JR
    Philos Trans A Math Phys Eng Sci; 2012 Aug; 370(1973):3924-49. PubMed ID: 22802496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous cell therapies: challenges in US FDA regulation.
    McAllister TN; Audley D; L'Heureux N
    Regen Med; 2012 Nov; 7(6 Suppl):94-7. PubMed ID: 23210819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global update: Scotland.
    Courtney A
    Regen Med; 2011 Nov; 6(6 Suppl):150-2. PubMed ID: 21999279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional Approval Pathways: The "Special" Case of Global Regenerative Medicine Regulation.
    Smith JA; Brindley DA
    Rejuvenation Res; 2017 Feb; 20(1):1-3. PubMed ID: 28125919
    [No Abstract]   [Full Text] [Related]  

  • 20. An audience with Ruth McKernan.
    McKernan R
    Nat Rev Drug Discov; 2009 Mar; 8(3):188. PubMed ID: 19247301
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.